KODIAK SCIENCES INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- KODIAK SCIENCES INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $2.92M, a 7594.74% increase year-over-year.
- KODIAK SCIENCES INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $721.00K, a 481.45% increase year-over-year.
- KODIAK SCIENCES INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $813.00K.
- KODIAK SCIENCES INC. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $38.00K.
- KODIAK SCIENCES INC. stock issued during period, value, stock options exercised for fiscal 2025 was $5.36M, a 1261.17% increase from fiscal 2024.
- KODIAK SCIENCES INC. stock issued during period, value, stock options exercised for fiscal 2024 was $394.00K, a 556.67% increase from fiscal 2023.
- KODIAK SCIENCES INC. stock issued during period, value, stock options exercised for fiscal 2023 was $60.00K, a 96.61% decline from fiscal 2022.
- KODIAK SCIENCES INC. stock issued during period, value, stock options exercised for fiscal 2022 was $1.77M, a 77.14% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $2.92M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $721.00K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $5.36M 10-K · filed 2026-03-31 | |
| 2025-09-30 | $813.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $38.00K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $124.00K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $394.00K 10-K · filed 2026-03-31 | |
| 2024-03-31 | $38.00K 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $60.00K 10-K · filed 2026-03-31 | |
| 2023-06-30 | $51.00K 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $9.00K 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $1.77M 10-K · filed 2025-03-27 | |
| 2022-09-30 | $90.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $2.00K 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $1.68M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $7.74M 10-K · filed 2024-03-28 | |
| 2021-09-30 | $2.04M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $2.23M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $1.48M 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $6.25M 10-K · filed 2023-03-28 | |
| 2020-09-30 | $813.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $720.00K 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $159.00K 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $2.29M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $272.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $59.00K 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $83.00K 10-Q · filed 2020-11-09 | |
| 2018-12-31 | $49.00K 10-K · filed 2021-03-01 | |
| 2018-09-30 | $49.00K 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $3.00K 10-K · filed 2020-03-16 | |
| 2016-12-31 | $5.00K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |